Thyroid Cancer

According to the American Cancer Society, thyroid cancer is diagnosed at a younger age than most other adult cancers.

Additionally, the majority of thyroid cancer cases (3 out of 4) are found in women. 

GoPath has developed several molecular tests to diagnose thyroid cancer and to detect genetic mutations that are associated with thyroid cancer. This means that our tests yield results that help your doctor create a treatment plan that's tailor-made to best treat your particular type of cancer. 

These tests include:

          •     Thyroid Profile - Analyzes genes associated with prognosis: BRAF, KRAS and NRAS
          •     RET FISH - Detects tumor growth-promoting RET gene rearrangements, which may influence treatment options
          •     ThyroiNowTM - Differentiates "indeterminate" biopsies, which may determine if surgery is needed
          •     OncoTargetTM - Detects genetic mutations in a tumor to monitor treatment resistance
          •     Thyroid Biopsy